Versatope Therapeutics

About:

Versatope is an immuno-therapeutic company that uses a biotechnology platform to delivery immunity.

Website: https://www.versatope.com

Twitter/X: VersatopeRx

Top Investors: National Institute of Allergy and Infectious Diseases, Massachusetts Life Sciences Center, MassVentures, MassChallenge

Description:

Versatope is an immuno-therapeutic company that uses a biotechnology platform to delivery immunity. The company develops a bacterial factory nano particle technology and multiple epitopes can be displayed to overcome strain-specific immunity, enabling biotechnology companies to develop a single vaccine to protect against multiple strains of influenza.

Total Funding Amount:

$21.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Lowell, Massachusetts, United States

Founded Date:

2017-01-01

Contact Email:

info(AT)versatope.com

Founders:

Christopher Locher

Number of Employees:

11-50

Last Funding Date:

2024-06-28

IPO Status:

Private

Industries:

© 2025 bioDAO.ai